Ocular Therapeutix
OCUL
#4790
Rank
S$2.79 B
Marketcap
S$12.74
Share price
-1.48%
Change (1 day)
-21.77%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -S$0.38 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are S$52.03 Million. In 2025 the company made an earning of -S$0.34 Billion a decrease over its 2024 earnings that were of -S$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.38 Billion9.81%
2025 -S$0.34 Billion37.43%
2024 -S$0.25 Billion139.68%
2023 -S$0.11 Billion13.65%
2022 -S$90.63 Million984.05%
2021 -S$8.36 Million-95.79%
2020 -S$0.2 Billion80.19%
2019 -S$0.12 Billion44.01%
2018 -S$76.52 Million-5.38%
2017 -S$80.87 Million41.79%
2016 -S$57.03 Million12.47%
2015 -S$50.71 Million38.75%
2014 -S$36.55 Million115.12%
2013 -S$16.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-S$14.3 Million-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-S$15.64 Million-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-S$0.21 Billion-44.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
S$0.19 B-153.95%๐Ÿ‡บ๐Ÿ‡ธ USA